In a wide-ranging interview with PharmaDispatch, AstraZeneca's Liz Chatwin talks about how the Australian market has changed, the opportunity for industry to be more strategic on key issues, the importance of manufacturing and R&D, and diversity.

Latest Video
New Stories
-
The grand US conspiracy against the PBS amounts to, nothing
April 1, 2025 - - Latest News -
Ipsen welcomes TGA registration of treatment for primary biliary cholangitis
April 1, 2025 - - Latest News -
First targeted treatment on the PBS for rare, unpredictable and debilitating autoimmune disease
April 1, 2025 - - Latest News -
Novo Nordisk forms Aboriginal and Torres Strait Islander Health Advisory Council
April 1, 2025 - - Latest News -
GSK brings Melbourne discovered treatment 'home' to Australian patients
April 1, 2025 - - Latest News -
Opthea announces decision to discontinue wet-AMD clinical trials
March 31, 2025 - - Australian Biotech -
BioNSW launches BioInvest Catalyst events to support life sciences investment in NSW
March 31, 2025 - - Australian Biotech